EOLS (STOCKS)
Evolus, Inc. Common Stock
$8.020000
-0.100000 (-1.23%)
Prev close: $8.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Moatazedi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $710.08M
- Employees
- 329
- P/E (TTM)
- -15.41
- P/B (TTM)
- -17.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.02 | $-0.04 | +0.0552 | +156.82% |
|
Mar 2026 (Q1)
|
$-0.05 | $-0.13 | +0.0826 | +62.29% |
|
Dec 2025 (Q4)
|
$0.05 | $0.05 | -0.0010 | -1.96% |
|
Sep 2025 (Q3)
|
$-0.11 | $-0.18 | +0.0660 | +37.50% |
Financial Statements
| Revenues | $316.49M |
| Benefits Costs and Expenses | $350.17M |
| Cost Of Revenue | $105.28M |
| Costs And Expenses | $229.88M |
| Gross Profit | $211.21M |
| Operating Expenses | $229.88M |
| Selling, General, and Administrative Expenses | $216.50M |
| Depreciation and Amortization | $5.66M |
| Other Operating Expenses | $7.72M |
| Operating Income/Loss | -$18.67M |
| Income/Loss From Continuing Operations After Tax | -$34.33M |
| Income/Loss From Continuing Operations Before Tax | -$33.68M |
| Income Tax Expense/Benefit | $654.00K |
| Income Tax Expense/Benefit, Deferred | -$583.00K |
| Net Income/Loss | -$34.33M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.33M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.52 |
| Diluted Earnings Per Share | -$0.52 |
| Basic Average Shares | 195,986,417 |
| Diluted Average Shares | 195,986,417 |
| Assets | $248.02M |
| Current Assets | $167.54M |
| Inventory | $40.90M |
| Prepaid Expenses | $4.45M |
| Other Current Assets | $122.20M |
| Noncurrent Assets | $80.48M |
| Fixed Assets | $5.05M |
| Intangible Assets | $45.69M |
| Other Non-current Assets | $29.74M |
| Liabilities | $278.93M |
| Current Liabilities | $98.73M |
| Accounts Payable | $44.48M |
| Wages | $11.14M |
| Other Current Liabilities | $43.11M |
| Noncurrent Liabilities | $180.20M |
| Long-term Debt | $156.74M |
| Other Non-current Liabilities | $23.45M |
| Equity | -$30.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$30.90M |
| Liabilities And Equity | $248.02M |
| Net Cash Flow From Operating Activities | -$15.38M |
| Net Cash Flow From Operating Activities, Continuing | -$15.38M |
| Net Cash Flow From Investing Activities | -$6.52M |
| Net Cash Flow From Investing Activities, Continuing | -$6.52M |
| Net Cash Flow From Financing Activities | $5.56M |
| Net Cash Flow From Financing Activities, Continuing | $5.56M |
| Exchange Gains/Losses | -$231.00K |
| Net Cash Flow | -$16.57M |
| Net Cash Flow, Continuing | -$16.34M |
| Comprehensive Income/Loss | -$34.26M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.26M |
| Other Comprehensive Income/Loss | -$34.26M |
| Other Comprehensive Income/Loss Attributable To Parent | $70.00K |